{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:11:54Z","timestamp":1790820714165,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"crossref","award":["5112-00001B"],"award-info":[{"award-number":["5112-00001B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejphar.2018.06.015","type":"journal-article","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T01:49:08Z","timestamp":1528508948000},"page":"255-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Pharmacological rescue of mutated Kv3.1 ion-channel linked to progressive myoclonus epilepsies"],"prefix":"10.1016","volume":"833","author":[{"given":"Anders Sonne","family":"Munch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnela","family":"Saljic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Boddum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Grunnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hougaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.06.015_bib1","unstructured":"Alvaro, G., Decor, A., Fontana, S., Hamprecht, D., Large, C., Marasco, A., 2011. Imidazolinedione derivatives. Patent WO 2011\/069951 A1."},{"key":"10.1016\/j.ejphar.2018.06.015_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM198607313150506","article-title":"Progressive myoclonus epilepsies: specific causes and diagnosis","volume":"315","author":"Berkovic","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2018.06.015_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuropharm.2017.02.024","article-title":"Kv3.1\/Kv3.2 channel positive modulators enable faster activating kinetics and increase firing frequency in fast-spiking GABAergic interneurons","volume":"118","author":"Boddum","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.06.015_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0306-4522(01)00277-9","article-title":"Properties of interneurones in the intermediolateral cell column of the rat spinal cord: role of the potassium channel subunit Kv3.1","volume":"106","author":"Deuchars","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2018.06.015_bib5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1523\/JNEUROSCI.16-02-00506.1996","article-title":"Developmental expression and functional characterization of the potassium-channel subunit Kv3.1b in parvalbumin-containing interneurons of the rat hippocampus","volume":"16","author":"Du","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.06.015_bib6","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1152\/jn.1999.82.5.2476","article-title":"Function of specific K+ channels in sustained high-frequency firing of fast-spiking neocortical interneurons","volume":"82","author":"Erisir","year":"1999","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2018.06.015_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1212\/WNL.0000000000000077","article-title":"Progressive myoclonic epilepsies: definitive and still undetermined causes","volume":"82","author":"Franceschetti","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2018.06.015_bib8","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1523\/JNEUROSCI.23-06-02058.2003","article-title":"Kv3 potassium conductance is necessary and kinetically optimized for high-frequency action potential generation in hippocampal interneurons","volume":"23","author":"Lien","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.06.015_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ng.3144","article-title":"A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy","volume":"47","author":"Muona","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2018.06.015_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.24929","article-title":"Myoclonus epilepsy and ataxia due to KCNC 1 mutation: analysis of 20 cases and K+ channel properties","volume":"81","author":"Oliver","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2018.06.015_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/jpet.115.225748","article-title":"A novel modulator of Kv3 potassium channels regulates the firing of parvalbumin-positive cortical interneurons","volume":"354","author":"Rosato-Siri","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.06.015_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0166-2236(00)01892-0","article-title":"Kv3 channels: voltage-gated K+ channels designed for high-frequency repetitive firing","volume":"24","author":"Rudy","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2018.06.015_bib13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nature07991","article-title":"Parvalbumin neurons and gamma rhythms enhance cortical circuit performance","volume":"459","author":"Sohal","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2018.06.015_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2015.03.061","article-title":"Biophysical characterization of Kv3.1 potassium channel activating compounds","volume":"758","author":"Taskin","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.06.015_bib15","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3","article-title":"Endogenous voltage-gated potassium channels in human embryonic kidney (HEK293) cells","volume":"52","author":"Yu","year":"1998","journal-title":"J. Neurosci. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T12:17:13Z","timestamp":1538396233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918303467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":15,"alternative-id":["S0014299918303467"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.06.015","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological rescue of mutated Kv3.1 ion-channel linked to progressive myoclonus epilepsies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}